Literature DB >> 2328030

C3 activation products correlate with antibodies to lipid A in pauciarticular juvenile arthritis.

L C Olds1, J J Miller.   

Abstract

IgM antibodies to monophosphoryl-lipid A were found to be elevated in sera from children with all forms of juvenile arthritis (JA) and systemic lupus erythematosus. Of more interest, in patients with pauciarticular JA, IgG antibody titers to monophosphoryl-lipid A were found to be correlated with the C3a concentration and the C3d:C3 ratio. Although the full specificity of these antibodies is unknown, they are the first that have been found to be correlated with complement activation products in any form of JA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328030     DOI: 10.1002/art.1780330409

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

Review 2.  Therapeutic modulation of cytokines.

Authors:  B Henderson
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

3.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

4.  Studies of the specificity and cross-reactions of antibodies to lipid A found in juvenile arthritis.

Authors:  J J Miller; L C Olds
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

Review 5.  Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.

Authors:  W P Arend
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.